Kurz gefasst
Fachartikel in der Zeitschrift MD Conference Express, 2006. Verfasst von L. Gater und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Liraglutide is a long-acting analog of glucagon-like peptide-1 (GLP-1). This article discusses phase 3 trials where this agent shows promise for the treatment of type 2 diabetes.
Zitieren
APA
Gater, L., & Madsbad, S. (2006). New Treatments: Liraglutide. MD Conference Express. https://doi.org/10.1177/155989770600600210
Vancouver
Gater L, Madsbad S. New Treatments: Liraglutide. MD Conference Express. 2006. doi:10.1177/155989770600600210
BibTeX
@article{Gater2006,
author = {Gater, L. and Madsbad, S.},
title = {New Treatments: Liraglutide},
journal = {MD Conference Express},
year = {2006},
doi = {10.1177/155989770600600210}
}
EUVIMED